We are live on ! Find out more
SFO

Stokes Family Office Portfolio holdings

AUM $969M
1-Year Est. Return 19.6%
This Fund
S&P 500
This Quarter Est. Return
+7.15%
1 Year Est. Return
+19.6%
3 Year Est. Return
+56.86%
5 Year Est. Return
+67.08%
10 Year Est. Return
AUM
$800M
AUM Growth
+$60.3M
Cap. Flow
+$13M
Cap. Flow %
1.62%
Top 10 Hldgs %
40.04%
Holding
234
New
13
Increased
93
Reduced
61
Closed
12

Sector Composition

Rank Sector Weight
1 Technology 10.56%
2 Healthcare 4.44%
3 Financials 3.99%
4 Consumer Staples 3.66%
5 Communication Services 3.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTUM icon
126
iShares MSCI USA Momentum Factor ETF
MTUM
$25.5B
$742K 0.09%
3,961
-27
-0.7% -$4.71K
CNQ icon
127
Canadian Natural Resources
CNQ
$93.8B
$726K 0.09%
19,034
+24
+0.1% +$803
VTV icon
128
Vanguard Morningstar Value ETF
VTV
$192B
$726K 0.09%
4,457
+26
+0.6% +$4.01K
MA icon
129
Mastercard
MA
$493B
$678K 0.08%
1,407
+23
+2% +$10.5K
GIGB icon
130
Goldman Sachs Access Investment Grade Corporate Bond ETF
GIGB
$973M
$673K 0.08%
14,694
-113,337
-89% -$5.18M
HCA icon
131
HCA Healthcare
HCA
$89.5B
$667K 0.08%
2,000
EMR icon
132
Emerson Electric
EMR
$88.3B
$651K 0.08%
5,741
-890
-13% -$91.4K
CAT icon
133
Caterpillar
CAT
$387B
$650K 0.08%
1,775
+275
+18% +$87.9K
RSP icon
134
Invesco S&P 500 Equal Weight ETF
RSP
$99.1B
$649K 0.08%
3,830
IBDS icon
135
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
$3.87B
$641K 0.08%
26,935
ZTS icon
136
Zoetis
ZTS
$30B
$636K 0.08%
3,761
+27
+0.7% +$5.06K
IBDX icon
137
iShares iBonds Dec 2032 Term Corporate ETF
IBDX
$1.74B
$628K 0.08%
25,330
+15,750
+164% +$390K
TSLA icon
138
Tesla
TSLA
$1.3T
$605K 0.08%
3,442
-195
-5% -$38.1K
SCHW
139
Charles Schwab
SCHW
$187B
$604K 0.08%
8,352
DHR icon
140
Danaher
DHR
$144B
$556K 0.07%
2,225
BTI icon
141
British American Tobacco
BTI
$128B
$545K 0.07%
17,878
+4,022
+29% +$121K
VLUE icon
142
iShares MSCI USA Value Factor ETF
VLUE
$9.47B
$531K 0.07%
4,905
-125
-2% -$12.8K
IBDT icon
143
iShares iBonds Dec 2028 Term Corporate ETF
IBDT
$4.07B
$530K 0.07%
21,295
NRP icon
144
Natural Resource Partners
NRP
$1.42B
$518K 0.06%
+5,625
New +$520K
AMGN icon
145
Amgen
AMGN
$222B
$505K 0.06%
1,775
+44
+3% +$12.9K
FCX icon
146
Freeport-McMoran
FCX
$97.5B
$502K 0.06%
10,677
+4,887
+84% +$197K
IJH icon
147
iShares Core S&P Mid-Cap ETF
IJH
$127B
$495K 0.06%
8,150
+10
+0.1% +$566
IJR icon
148
iShares Core S&P Small-Cap ETF
IJR
$112B
$485K 0.06%
4,391
+4
+0.1% +$425
IBDV icon
149
iShares iBonds Dec 2030 Term Corporate ETF
IBDV
$3.3B
$478K 0.06%
22,345
+2,000
+10% +$42.8K
IBDW icon
150
iShares iBonds Dec 2031 Term Corporate ETF
IBDW
$2.55B
$476K 0.06%
23,230
+2,100
+10% +$42.9K

Similar funds

Stokes Family Office's Q1 2024 Portfolio in Review

As of Q1 2024, Stokes Family Office held 234 positions worth $800M, up 8.1% from $740M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Stokes Family Office's Q1 2024 filing shows 13 new, 93 increased, 61 reduced and 12 closed positions. Its largest new stake was BlackRock US Equity Factor Rotation ETF: 512,015 shares worth $22.7M. The largest sale was iShares US Equity Factor ETF, an estimated $27.1M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Financials.

  • Stokes Family Office's largest Q1 2024 buy was BlackRock US Equity Factor Rotation ETF: 512,015 shares worth $22.7M.
  • Stokes Family Office added most to iShares S&P 500 Value ETF in Q1 2024, an estimated $12.6M increase.
  • Stokes Family Office's biggest Q1 2024 reduction was iShares US Equity Factor ETF, cutting an estimated $27.1M.
  • Stokes Family Office fully exited iShares S&P 100 ETF in Q1 2024, selling an estimated $13.3M.
  • Stokes Family Office's ten largest holdings make up 40% of its $800M portfolio in Q1 2024.
  • Stokes Family Office opened 13 new positions and closed 12 in Q1 2024.
  • Stokes Family Office's portfolio value rose 8.1% quarter-over-quarter to $800M.

Based on Stokes Family Office's 13F filing for Q1 2024, filed 6 May 2024.